Coexpression of somatostatin receptor subtype 5 affects internalization and trafficking of somatostatin receptor subtype 2

Endocrinology

Volumn 148, Issue 5, 2007, Pages 2095-2105

  Sharif, Nadder ^a   Gendron, Louis ^a,c   Wowchuk, Julia ^a   Sarret, Philippe ^a,c   Mazella, Jean ^b   Beaudet, Alain ^a   Stroh, Thomas ^a  

^a MCGILL UNIVERSITY   (Canada)

^b INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^c UNIVERSITY OF SHERBROOKE   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP; FORSKOLIN; L 779976; LIGAND; SOMATOSTATIN 14; SOMATOSTATIN DERIVATIVE; SOMATOSTATIN RECEPTOR 2; SOMATOSTATIN RECEPTOR 5; SOMATOSTATIN[8 DEXTRO TRYPTOPHAN]; UNCLASSIFIED DRUG; AMIDE; DIAGNOSTIC AGENT; DRUG DERIVATIVE; INDOLE DERIVATIVE; RADIOACTIVE IODINE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR SST2A; SOMATOSTATIN, TRP(8); SOMATOSTATIN, TRP(8)-;

AGONIST; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BINDING SITE; CELL LINE; CELL MIGRATION; CELL STIMULATION; CELL SURFACE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; ENDOCYTOSIS; GENETIC TRANSFECTION; HORMONE TRANSPORT; HYPOPHYSIS CELL; INTERNALIZATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; ANIMAL; CHO CELL; CRICETULUS; DRUG POTENTIATION; GENETICS; HAMSTER; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; RADIOASSAY; SIGNAL TRANSDUCTION;

AMIDES; ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; CYCLIC AMP; ENDOCYTOSIS; FORSKOLIN; INDOLES; IODINE RADIOISOTOPES; MICE; PROTEIN TRANSPORT; RADIOLIGAND ASSAY; RECEPTORS, SOMATOSTATIN; SIGNAL TRANSDUCTION; SOMATOSTATIN; TRANSFECTION;

EID: 34249792384     PISSN: 00137227     EISSN: 00137227     Source Type: Journal    
DOI: 10.1210/en.2006-1266     Document Type: Article

References (51)

1. Brazeau P, Vale W, Burgus R, Ling N, Butcher M, Rivier J, Guillemin R 1973 Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone. Science 179:77-79
2. Patel YC 1992 General aspects of the biology and function of somatostatin. In: Weil C, Müller EE, Thorner MO, eds. Somatostatin. Berlin: Springer; 1-16
3. Epelbaum J, Dournaud P, Fodor M, Viollet C 1994 The neurobiology of somatostatin. Crit Rev Neurobiol 8:25-44
4. Tannenbaum GS, Epelbaum J 1999 Somatostatin. In: Kostyo JL, Goodman HM, eds. Handbook of physiology: the endocrine system. New York: Oxford University Press; 221-265
5. Heaney AP, Melmed S 2004 Molecular targets in pituitary tumours. Nat Rev Cancer 4:285-295
6. Csaba Z, Dournaud P 2001 Cellular biology of somatostatin receptors. Neuropeptides 35:1-23
7. Day R, Dong W, Panetta R, Kraicer J, Greenwood MT, Patel YC 1995 Expression of mRNA for somatostatin receptor (sstr) types 2 and 5 in individual rat pituitary cells. A double labeling in situ hybridization analysis. Endocrinology 136:5232-5235
8. O'Carroll AM, Krempels K 1995 Widespread distribution of somatostatin receptor messenger ribonucleic acids in rat pituitary. Endocrinology 136:5224-5227
9. Thoss VS, Perez J, Probst A, Hoyer D 1996 Expression of five somatostatin receptor mRNAs in the human brain and pituitary. Naunyn Schmiedebergs Arch Pharmacol 354:411-419
10. Kumar U, Laird D, Srikant CB, Escher E, Patel YC 1997 Expression of the five somatostatin receptor (SSTR1-5) subtypes in rat pituitary somatotrophes: quantitative analysis by double-layer immunofluorescence confocal microscopy. Endocrinology 138:4473-4476
11. 5 somatostatin receptors in the rat anterior pituitary. Endocrinology 139:414-419
12. Shimon I, Taylor JE, Dong JZ, Bitonte RA, Kim S, Morgan B, Coy DH, Culler MD, Melmed S 1997 Somatostatin receptor subtype specificity in human fetal pituitary cultures. Differential role of SSTR2 and SSTR5 for growth hormone, thyroid-stimulating hormone, and prolactin regulation. J Clin Invest 99:789-798
13. Shimon I, Yan X, Taylor JE, Weiss MH, Culler MD, Melmed S 1997 Somatostatin receptor (SSTR) subtype-selective analogues differentially suppress in vitro growth hormone and prolactin in human pituitary adenomas. Novel potential therapy for functional pituitary tumors. J Clin Invest 100:2386-2392
14. Jaquet P, Saveanu A, Gunz G, Fina F, Zamora AJ, Grino M, Culler MD, Moreau JP, Enjalbert A, Ouafik LH 2000 Human somatostatin receptor subtypes in acromegaly: distinct patterns of messenger ribonucleic acid expression and hormone suppression identify different tumoral phenotypes. J Clin Endocrinol Metab 85:781-792
15. Ren SG, Taylor J, Dong J, Yu R, Culler MD, Melmed S 2003 Functional association of somatostatin receptor subtypes 2 and 5 in inhibiting human growth hormone secretion. J Clin Endocrinol Metab 88:4239-4245
16. Strowski MZ, Dashkevicz MP, Parmar RM, Wilkinson H, Kohler M, Schaeffer JM, Blake AD 2002 Somatostatin receptor subtypes 2 and 5 inhibit corticotropin-releasing hormone-stimulated adrenocorticotropin secretion from AtT-20 cells. Neuroendocrinology 75:339-346
17. Muller AF, Van Der Lely AJ 2004 Pharmacological therapy for acromegaly: a critical review. Drugs 64:1817-1838
18. Hofland LJ, Lamberts SW 2003 The pathophysiological consequences of somatostatin receptor internalization and resistance. Endocr Rev 24:28-47
19. Roosterman D, Roth A, Kreienkamp HJ, Richter D, Meyerhof W 1997 Distinct agonist-mediated endocytosis of cloned rat somatostatin receptor subtypes expressed in insulinoma cells. J Neuroendocrinol 9:741-751
20. Sarret P, Nouel D, Dal Farra C, Vincent JP, Beaudet A, Mazella J 1999 Receptor-mediated internalization is critical for the inhibition of the expression of growth hormone by somatostatin in the pituitary cell line AtT-20. J Biol Chem 274:19294-19300
21. Sarret P, Esdaile MJ, McPherson PS, Schonbrunn A, Kreienkamp HJ, Beaudet A 2004 Role of amphiphysin II in somatostatin receptor trafficking in neuroendocrine cells. J Biol Chem 279:8029-8037
22. Tulipano G, Stumm R, Pfeiffer M, Kreienkamp HJ, Höllt V, Schulz S 2004 Differential β-arrestin trafficking and endosomal sorting of somatostatin receptor subtypes. J Biol Chem 279:21374-21382
23. Hukovic N, Panetta R, Kumar U, Patel YC 1996 Agonist-dependent regulation of cloned human somatostatin receptor types 1-5 (hSSTR1-5): subtype selective internalization or upregulation. Endocrinology 137:4046-4049
24. 2A somatostatin receptor. J Biol Chem 272:13869-13876
25. Nouel D, Gaudriault G, Houle M, Reisine T, Vincent JP, Mazella J, Beaudet A 1997 Differential internalization of somatostatin in COS-7 cells transfected with SST1 and SST2 receptor subtypes: a confocal microscopic study using novel fluorescent somatostatin derivatives. Endocrinology 138:296-306
26. Roth A, Kreienkamp HJ, Nehring RB, Roosterman D, Meyerhof W, Richter D 1997 Endocytosis of the rat somatostatin receptors: subtype discrimination, ligand specificity, and delineation of carboxy-terminal positive and negative sequence motifs. DNA Cell Biol 16:111-119
27. Stroh T, Jackson AC, Sarret P, Dal Farra C, Vincent JP, Kreienkamp HJ, Mazella J, Beaudet A 2000 Intracellular dynamics of sst5 receptors in transfected COS-7 cells: maintenance of cell surface receptors during ligand-induced endocytosis. Endocrinology 141:354-365
28. 8- somatostatin: an analog of somatostatin more potent than the native molecule. Biochem Biophys Res Commun 65:746-751
29. Reubi JC, Perrin M, Rivier J, Vale W 1982 Pituitary somatostatin receptors: dissociation at the pituitary level of receptor affinity and biological activity for selective somatostatin analogs. Regul Pept 4:141-146
30. Rohrer SP, Birzin ET, Mosley RT, Berk SC, Hutchins SM, Shen DM, Xiong Y, Hayes EC, Parmar RM, Foor F, Mitra SW, Degrado SJ, Shu M, Klopp JM, Cai SJ, Blake A, Chan WW, Pasternak A, Yang L, Patchett AA, Smith RG, Chapman KT, Schaeffer JM 1998 Rapid identification of subtype-selective agonists of the somatostatin receptor through combinatorial chemistry. Science 282:737-740
31. Yang L, Berk SC, Rohrer SP, Mosley RT, Guo L, Underwood DJ, Arison BH, Birzin ET, Hayes EC, Mitra SW, Parmar RM, Cheng K, Wu TJ, Butler BS, Foor F, Pasternak A, Pan Y, Silva M, Freidinger RM, Smith RG, Chapman K, Schaeffer JM, Patchett AA 1998 Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc Natl Acad Sci USA 95:10836-10841
32. Hertel C, Coulter SJ, Perkins JP 1985 A comparison of catecholamine-induced internalization of β-adrenergic receptors and receptor-mediated endocytosis of epidermal growth factor in human astrocytoma cells. Inhibition by phenylarsine oxide. J Biol Chem 260:12547-12553
33. Koenig JA, Edwardson JM 1997 Endocytosis and recycling of G protein-coupled receptors. Trends Pharmacol Sci 18:276-287
34. 2A in the rat spinal cord and dorsal root ganglia. Eur J Neurosci 10:3700-3708
35. Green R, Shields D 1984 Somatostatin discriminates between the intracellular pathways of secretory and membrane proteins. J Cell Biol 99:97-104
36. Beaumont V, Hepworth MB, Luty JS, Kelly E, Henderson G 1998 Somatostatin receptor desensitization in NG108-15 cells. A consequence of receptor sequestration. J Biol Chem 273:33174-33183
37. i/o-protein, but not to the serum response element in AtT-20 mouse tumour corticotrophs. Naunyn Schmiedebergs Arch Pharmacol 367:578-587
38. Patel YC, Srikant CB 1994 Subtype selectivity of peptide analogs for all five cloned human somatostatin receptors (hsstr 1-5). Endocrinology 135:2814-2817
39. Bruns C, Raulf F, Hoyer D, Schloos J, Lübbert H, Weckbecker G 1996 Binding properties of somatostatin receptor subtypes. Metabolism 45:17-20
40. Liapakis G, Tallent M, Reisine T 1996 Molecular and functional properties of somatostain receptor subtypes. Metabolism 45:12-13
41. Olias G, Viollet C, Kusserow H, Epelbaum J, Meyerhof W 2004 Regulation and function of somatostatin receptors. J Neurochem 89:1057-1091
42. Mazza FC, Blake AD 2004 Differential desensitization of somatostatin receptor subtypes in AtT-20 cells. Protein Pept Lett 11:141-147
43. 2A somatostatin receptor. J Biol Chem 275:5591-5599
44. Liu Q, Cescato R, Dewi DA, Rivier J, Reubi JC, Schonbrunn A 2005 Receptor signaling and endocytosis are differentially regulated by somatostatin analogs. Mol Pharmacol 68:90-101
45. Brasselet S, Guillen S, Vincent JP, Mazella J 2002 β-Arrestin is involved in the desensitization but not in the internalization of the somatostatin receptor 2A expressed in CHO cells. FEBS Lett 516:124-128
46. Perron A, Sharif N, Gendron L, Stroh T, Beaudet A 2007 NTS2 modulates NTS1 expression and internalization via heterodimerization. Biochem Biophys Res Commun 353:582-590
47. Rocheville M, Lange DC, Kumar U, Patel SC, Patel RC, Patel YC 2000 Receptors for dopamine and somatostatin: formation of hetero-oligomers with enhanced functional activity. Science 288:154-157
48. Rocheville M, Lange DC, Kumar U, Sasi R, Patel RC, Patel YC 2000 Subtypes of the somatostatin receptor assemble as functional homo- and heterodimers. J Biol Chem 275:7862-7869
49. 2A. J Biol Chem 276:14027-14036
50. Grant M, Collier B, Kumar U 2004 Agonist-dependent dissociation of human somatostatin receptor 2 dimers: a role in receptor trafficking. J Biol Chem 279:36179-36183
51. Ben-Shlomo A, Wawrowsky KA, Proekt I, Wolkenfeld NM, Ren SG, Taylor J, Culler MD, Melmed S 2005 Somatostatin receptor type 5 modulates somatostatin receptor type 2 regulation of adrenocorticotropin secretion. J Biol Chem 280:24011-24021